These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 28759632

  • 1. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    Kim G, Kim KJ, Rhee Y, Lim SK.
    PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
    [Abstract] [Full Text] [Related]

  • 2. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
    Ciardullo S, Muraca E, Zerbini F, Manzoni G, Perseghin G.
    J Clin Endocrinol Metab; 2021 Jul 13; 106(8):e2856-e2865. PubMed ID: 33878156
    [Abstract] [Full Text] [Related]

  • 3. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
    Zhang W, Li Y, Li S, Zhou J, Wang K, Li Z, Chen N, Chen X.
    Front Endocrinol (Lausanne); 2023 Jul 13; 14():1278505. PubMed ID: 38116314
    [Abstract] [Full Text] [Related]

  • 4. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.
    Zhu X, Yan H, Chang X, Xia M, Zhang L, Wang L, Sun X, Yang X, Gao X, Bian H.
    BMJ Open Diabetes Res Care; 2020 Aug 13; 8(1):. PubMed ID: 32759166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH.
    Dig Dis Sci; 2017 Aug 13; 62(8):2150-2158. PubMed ID: 28523578
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.
    Lee SH, Yun JM, Kim SH, Seo YG, Min H, Chung E, Bae YS, Ryou IS, Cho B.
    J Endocrinol Invest; 2016 Nov 13; 39(11):1329-1336. PubMed ID: 27561910
    [Abstract] [Full Text] [Related]

  • 11. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Ahn SH, Seo DH, Kim SH, Nam MS, Hong S.
    Osteoporos Int; 2018 Jan 13; 29(1):181-190. PubMed ID: 29051986
    [Abstract] [Full Text] [Related]

  • 12. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH, Kim KJ, Kim SU, Han SH, Han KH, Cha BS, Chung CH, Lee BW.
    Metabolism; 2017 Jan 13; 66():23-31. PubMed ID: 27923446
    [Abstract] [Full Text] [Related]

  • 13. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.
    Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G, Lippi G, Zoppini G, Byrne CD, Bonora E, Targher G.
    Diabetes Metab; 2019 Sep 13; 45(4):347-355. PubMed ID: 30315891
    [Abstract] [Full Text] [Related]

  • 14. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH, Kim KJ, Yoo ME, Kim G, Yoon HJ, Jo K, Youn JC, Yun M, Park JY, Shim CY, Lee BW, Kang SM, Ha JW, Cha BS, Kang ES.
    J Hepatol; 2018 Apr 13; 68(4):764-772. PubMed ID: 29175242
    [Abstract] [Full Text] [Related]

  • 15. Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease.
    Barchetta I, Lubrano C, Cimini FA, Dule S, Passarella G, Dellanno A, Di Biasio A, Leonetti F, Silecchia G, Lenzi A, Cavallo MG.
    Hepatol Int; 2023 Apr 13; 17(2):357-366. PubMed ID: 36520377
    [Abstract] [Full Text] [Related]

  • 16. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK.
    J Gastroenterol Hepatol; 2019 Aug 13; 34(8):1396-1403. PubMed ID: 30551263
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014.
    Zhai T, Chen Q, Xu J, Jia X, Xia P.
    Front Endocrinol (Lausanne); 2021 Aug 13; 12():825448. PubMed ID: 35126317
    [Abstract] [Full Text] [Related]

  • 18. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
    Böttcher J, Pfeil A, Lehmann G, Heinrich B, Malich A, Hansch A, Petrovitch A, Mentzel HJ, Hein G, Kaiser WA.
    Z Rheumatol; 2004 Dec 13; 63(6):473-82. PubMed ID: 15605213
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A, Pulsombat A, Kaewdoung P, Petraksa S.
    Asian Pac J Cancer Prev; 2015 Dec 13; 16(5):1789-94. PubMed ID: 25773826
    [Abstract] [Full Text] [Related]

  • 20. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
    Conti F, Vukotic R, Foschi FG, Domenicali M, Giacomoni P, Savini S, Lanzi A, Dall'Aglio AC, Saini G, Matroroberto M, Bernardi M, Stefanini GF, Andreone P.
    Dig Liver Dis; 2016 Nov 13; 48(11):1357-1363. PubMed ID: 27522549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.